Search alternatives:
significant increases » significant increase (Expand Search), significantly increased (Expand Search), significant decrease (Expand Search)
increases decrease » increased release (Expand Search)
significant fold » significant force (Expand Search), significant co (Expand Search), significant body (Expand Search)
fold increased » fold increase (Expand Search), could increase (Expand Search)
Showing 41 - 60 results of 57,991 for search '(( significant fold increased ) OR ( significant increases decrease ))', query time: 0.96s Refine Results
  1. 41
    DNA concentrations of ucfDNA across WT, <i>Dnase1l3</i><sup>-/-</sup> and <i>Dnase1</i><sup><i>-/-</i></sup> mice with quantifiable ucfDNA using Qubit assay.

    DNA concentrations of ucfDNA across WT, <i>Dnase1l3</i><sup>-/-</sup> and <i>Dnase1</i><sup><i>-/-</i></sup> mice with quantifiable ucfDNA using Qubit assay. by Meihui Chen (1670020)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  2. 42
    Overview of the study design.

    Overview of the study design. by Meihui Chen (1670020)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  3. 43
    The end density of ucfDNA across different tissue types.

    The end density of ucfDNA across different tissue types. by Meihui Chen (1670020)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  4. 44
    End density of the ucfDNA fragments within the DHSs.

    End density of the ucfDNA fragments within the DHSs. by Meihui Chen (1670020)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  5. 45
    Percentages of ucfDNA fragments starting with T.

    Percentages of ucfDNA fragments starting with T. by Meihui Chen (1670020)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  6. 46
    Comparison of <i>DNASE1</i> mRNA expression levels in bladder tumoral tissues (n = 41) and adjacent non-tumoral tissues (n = 19) using the TCGA dataset.

    Comparison of <i>DNASE1</i> mRNA expression levels in bladder tumoral tissues (n = 41) and adjacent non-tumoral tissues (n = 19) using the TCGA dataset. by Meihui Chen (1670020)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  7. 47
    S8 Fig -

    S8 Fig - by Meihui Chen (1670020)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  8. 48
    DNA concentrations of ucfDNA in WT, <i>Dnase1l3</i><sup>-/-</sup> and <i>Dnase1</i><sup>-/-</sup> mice.

    DNA concentrations of ucfDNA in WT, <i>Dnase1l3</i><sup>-/-</sup> and <i>Dnase1</i><sup>-/-</sup> mice. by Meihui Chen (1670020)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  9. 49
    S5 Fig -

    S5 Fig - by Meihui Chen (1670020)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  10. 50
    Western blot and zymogram analysis of DNASE1 and DNASE1L3 in urine and plasma samples from healthy human subjects and C57BL/6 mice.

    Western blot and zymogram analysis of DNASE1 and DNASE1L3 in urine and plasma samples from healthy human subjects and C57BL/6 mice. by Meihui Chen (1670020)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  11. 51
    Jagged index-unmethylated (JI-U) values of ucfDNA.

    Jagged index-unmethylated (JI-U) values of ucfDNA. by Meihui Chen (1670020)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  12. 52
    Proportion of human ucfDNA molecules falling within the DHSs.

    Proportion of human ucfDNA molecules falling within the DHSs. by Meihui Chen (1670020)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  13. 53
    Δ<i>osmB</i> has increased <i>in vivo</i> fitness relative to the WT strain, Δ<i>ompF</i> does not appear significantly more susceptible to doxycycline <i>in vivo</i>.

    Δ<i>osmB</i> has increased <i>in vivo</i> fitness relative to the WT strain, Δ<i>ompF</i> does not appear significantly more susceptible to doxycycline <i>in vivo</i>. by Hector S. Alvarez-Manzo (12551730)

    Published 2022
    Save to List
    Saved in:
  14. 54
    Increased and decreased proteins.

    Increased and decreased proteins. by Diego Iacono (10785756)

    Published 2024
    Save to List
    Saved in:
  15. 55
    Treatment with ICs causes a significant decrease in podocyte proliferation.

    Treatment with ICs causes a significant decrease in podocyte proliferation. by George Haddad (470789)

    Published 2023
    Save to List
    Saved in:
  16. 56
    Relations between Lnc THRIL and MiR-125b and clinical data in UC patients.

    Relations between Lnc THRIL and MiR-125b and clinical data in UC patients. by Azza Elamir (13924199)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  17. 57
    Correlations of Lnc THRIL and MiR 125b with study parameters among UC patients.

    Correlations of Lnc THRIL and MiR 125b with study parameters among UC patients. by Azza Elamir (13924199)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  18. 58
    Demographic, biochemical and clinical characteristics of the study groups.

    Demographic, biochemical and clinical characteristics of the study groups. by Azza Elamir (13924199)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  19. 59
    Receiver operating characteristic of sensitivity and specificity of Lnc THRIL and MiR-125b in CD patients vs. controls.

    Receiver operating characteristic of sensitivity and specificity of Lnc THRIL and MiR-125b in CD patients vs. controls. by Azza Elamir (13924199)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  20. 60
    Relations between Lnc THRIL and MiR-125b and clinical data in CD patients.

    Relations between Lnc THRIL and MiR-125b and clinical data in CD patients. by Azza Elamir (13924199)

    Published 2022
    Subjects:
    Save to List
    Saved in:

Search Tools: